Nab 365 (Clenbuterol, Planipart TM) for the Postponement of Parturition and Alleviation of Dystocia in Cattle
Abstract
This study was done for Boehringer Ingelheim Inc. Boehringer Ingelheim Inc. is submitting this drug to the United States Department of Food and Drug Administration for use in the United States. The primary objective is to document efficacy reported in European studies.
Collections
- OSU Theses [15752]